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Clinical Vignette
A 63-year-old diabetic woman with end-stage renal 
disease (ESRD) presented with a 4-month history of 
progressive back pain, weight loss and a 3-week history 
of increasing motion restriction. She had been on 
hemodialysis for 3 years when all her symptoms devel-
oped. She was vaccinated with Bacillus Calmette-
Guérin (BCG) vaccine at the age of 17. On admission, 
her purified protein-derivative of tuberculin (PPD) 
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Panel A. Sagittal T1- and T2-weighted and coronal T2-weighted magnetic resonance images of the thoracic spine taken on admission.
Panel B. Magnetic resonance images (at the same level as Panel A) taken after treatment.
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skin test and QuantiFERON-TB Gold (QFT-G) test 
were negative. Sagittal T1- and T2-weighted and coro-
nal T2-weighted magnetic resonance imaging of the 
thoracic spine (Panel A) showed the involvement of 
the 5th and 6th thoracic vertebrae in the infectious 
process with bone destruction and paravertebral, pre-
vertebral and epidural high signal collections, the latter 
causing myelon compression. Magnetic resonance 
imaging after 12 months of supervised antituberculous 
treatment showed full resorption of the collections 
(Panel B).
Renal failure heightens susceptibility to tuberculous 
infections. Patients with renal failure do not respond 
normally to intracellular infections like those caused by 
Mycobacterium tuberculosis because of their abnormal 
T-cell-mediated immunity [1]. Because of this, neither 
PPD and QFT-G tests are sufficient for diagnosis nor 
childhood BCG vaccination for protection in patients 
with ESRD, but supervised antituberculous treatment 
is well-tolerated and effective.
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